Crypto
Axsome Therapeutics' rStock Sees Rapid Market Growth Amid Central Nervous System Disorders Focus
Axsome Therapeutics, Inc.'s rStock is a commercial-stage biopharmaceutical company that develops novel therapies for central nervous system disorders. The current market cap of Axsome Therapeutics, Inc. rStock is CA$0.00.
The trading volume of Axsome Therapeutics, Inc. rStock over the last 24 hours is also CA$0.00. Assets with similar market caps include Westinghouse Air Brake Technologies (Wabtec) rStock, Venture Global LNG Inc rStock, and Tradr 2X Long SNDK Daily ETF rStock.
The current circulating supply of Axsome Therapeutics, Inc. rStock is 0. In terms of performance, RAXSM has increased by 52.73% compared to markets and by 49.27% compared to BTC over the same period.